Literature DB >> 24101363

Long-term trends in incidence, survival and mortality of primary penile cancer in England.

Manit Arya1, Ruoran Li, Kat Pegler, Vijay Sangar, John D Kelly, Suks Minhas, Asif Muneer, Michel P Coleman.   

Abstract

PURPOSE: Few population-based studies exist of long-term trends in penile cancer. We report incidence and mortality trends in England over the 31 years 1979-2009 and survival trends over the 40 years 1971-2010.
METHODS: We calculated annual incidence and mortality rates per 100,000 by age and calendar period. We estimated incidence and mortality rate ratios for cohorts born since 1890, and one- and five-year relative survival (%) by age and deprivation category.
RESULTS: A total of 9,690 men were diagnosed with penile cancer during 1979-2009. Age-standardized incidence rates increased by 21 %, from 1.10 to 1.33 per 100,000. Mortality rates fell by 20 % after 1994, from 0.39 to 0.31 per 100,000. Survival analyses included 11,478 men diagnosed during 1971-2010. Five-year relative survival increased from 61.4 to 70.2 %. Five-year survival for men diagnosed 2006-2010 was 77 % for men aged under 60 years and 53 % for men aged 80-99 years. The 8 % difference in five-year survival (66-74 %) between men in the most affluent and most deprived groups was not statistically significant.
CONCLUSIONS: The 21 % increase in penile cancer incidence in England since the 1970s may be explained by changes in sexual practice, greater exposure to sexually transmitted oncogenic human papilloma viruses, and decreasing rates of childhood circumcision. Improvement in survival is likely due to advances in diagnostic, staging and surgical techniques. There is a need for public health education and potential preventative strategies to address the increasing incidence.

Entities:  

Mesh:

Year:  2013        PMID: 24101363     DOI: 10.1007/s10552-013-0293-y

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  26 in total

1.  [Organ-preserving therapy for penile carcinoma].

Authors:  O W Hakenberg; C Protzel
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

2.  [Urethral centralization and pseudo-glans formation after partial penectomy].

Authors:  J Kranz; A Parnham; M Albersen; V Sahdev; M Ziada; R Nigam; A Muneer; J Steffens; P Malone
Journal:  Urologe A       Date:  2017-10       Impact factor: 0.639

Review 3.  Challenges and controversies in the management of penile cancer.

Authors:  Majid Shabbir; Oliver Kayes; Suks Minhas
Journal:  Nat Rev Urol       Date:  2014-11-18       Impact factor: 14.432

4.  Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer.

Authors:  Andrew Feber; Manit Arya; Patricia de Winter; Muhammad Saqib; Raj Nigam; Peter R Malone; Wei Shen Tan; Simon Rodney; Matthias Lechner; Alex Freeman; Charles Jameson; Asif Muneer; Stephan Beck; John D Kelly
Journal:  Clin Cancer Res       Date:  2014-12-23       Impact factor: 12.531

Review 5.  What is the medical evidence on non-therapeutic child circumcision?

Authors:  Matthew Deacon; Gordon Muir
Journal:  Int J Impot Res       Date:  2022-01-08       Impact factor: 2.896

6.  Trends in Incidence, Mortality, and Survival of Penile Cancer in the United States: A Population-Based Study.

Authors:  Xinxi Deng; Yang Liu; Xiangpeng Zhan; Tao Chen; Ming Jiang; Xinhao Jiang; Luyao Chen; Bin Fu
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

7.  Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life.

Authors:  Gennaro Musi; Andrea Russo; Andrea Conti; Francesco A Mistretta; Ettore Di Trapani; Stefano Luzzago; Roberto Bianchi; Giuseppe Renne; Stefano Ramoni; Matteo Ferro; Deliu Victor Matei; Marco Cusini; Luca Carmignani; Ottavio de Cobelli
Journal:  World J Urol       Date:  2017-12-02       Impact factor: 4.226

8.  CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.

Authors:  Daniel C Worth; Ankur Chakravarthy; Andrew Feber; Patricia de Winter; Kunal Shah; Manit Arya; Muhammad Saqib; Raj Nigam; Peter R Malone; Wei Shen Tan; Simon Rodney; Alex Freeman; Charles Jameson; Gareth A Wilson; Tom Powles; Stephan Beck; Tim Fenton; Tyson V Sharp; Asif Muneer; John D Kelly
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

9.  Development and Verification of Prognostic Nomogram for Penile Cancer Based on the SEER Database.

Authors:  Yon-Bo Chen; Ying-Wen Liu; Liang Gao; Liang-You Tang; Jiang Guo; Yu-Chang Tian; Ping-Hong You
Journal:  Biomed Res Int       Date:  2022-04-04       Impact factor: 3.411

Review 10.  Understanding genomics and the immune environment of penile cancer to improve therapy.

Authors:  Ahmet Murat Aydin; Jad Chahoud; Jacob J Adashek; Mounsif Azizi; Anthony Magliocco; Jeffrey S Ross; Andrea Necchi; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2020-08-18       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.